Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

TRANSPOSAGEN BIOPHARMACEUTICALS, INC. SBIR Phase II Award,

A SBIR Phase II contract was awarded to TRANSPOSAGEN BIOPHARMACEUTICALS, INC. for $650,666.0 USD from the U.S. Department of Health & Human Services.

OverviewStructured DataIssuesContributorsActivity

Currently, there are no issues on this topic.

Find more entities like TRANSPOSAGEN BIOPHARMACEUTICALS, INC. SBIR Phase II Award,

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo